Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

73.66EUR
12:35pm EDT
Price Change (% chg)

€1.75 (+2.43%)
Prev Close
€71.91
Open
€73.32
Day's High
€74.28
Day's Low
€72.70
Volume
6,621,319
Avg. Vol
3,568,475
52-wk High
€89.95
52-wk Low
€68.29

SASY.PA

Chart for SASY.PA

About

Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi focuses on the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer... (more)

Overall

Beta: 0.64
Market Cap (Mil.): €95,422.80
Shares Outstanding (Mil.): 1,326.97
Dividend: 2.80
Yield (%): 3.89

Financials

  SASY.PA Industry Sector
P/E (TTM): 23.30 32.70 33.67
EPS (TTM): 3.09 -- --
ROI: -- 18.12 17.39
ROE: -- 18.79 18.21
Search Stocks

Novo Nordisk reassures on 2015 outlook after Sanofi jolt

COPENHAGEN - Novo Nordisk reassured investors that its diabetes drugs business in the United States would continue to grow, after French rival Sanofi warned that price competition would hamper its U.S. sales.

30 Oct 2014

BRIEF-Smith & Nephew CEO declines to comment on Sanofi CEO role

* Ceo olivier bohuon declines to comment on any interest in sanofi CEO role Further company coverage:

30 Oct 2014

UPDATE 3-Novo Nordisk reassures on 2015 outlook after Sanofi jolt

* Shares up almost 4 percent (Adds analysts, details on Tresiba, updates shares)

30 Oct 2014

Power of "France Inc" on display in Sanofi boardroom coup

PARIS, Oct 30 - Events at Sanofi this week cost a high-flying German-Canadian boss his job and global investors billions. They are also a reminder that corporate France carries the national interest in its DNA, and neglects its family duties at its peril.

30 Oct 2014

French drugmaker Sanofi sacks CEO, shares drop

PARIS - Sanofi's board ousted its chief executive of six years on Wednesday, criticizing him for an authoritarian management style that was often popular with investors as he lifted the French drugmaker onto the global stage.

29 Oct 2014

UPDATE 6-French drugmaker Sanofi sacks CEO, shares drop

* Chairman Weinberg cites poor relations between CEO, board

29 Oct 2014

BUSINESS-NEWS-SCHEDULE AT 1330 GMT /9.30 AM ET

Editor: Malcolm Davidson +44 20 7542 6958

29 Oct 2014

Behind the scenes of Sanofi's boardroom bust up

PARIS - A boardroom tussle brewing for months at Sanofi came to a head on Wednesday when France's top drugmaker fired its chief executive, wiping more billions off its share price.

29 Oct 2014

UPDATE 1-Behind the scenes of Sanofi's boardroom bust up

* Viehbacher wanted free hand to steer company (Recasts with eviction of CEO, Weinberg quotes, background)

29 Oct 2014

European shares inch higher; Sanofi drops again

* FTSEurofirst 300 up 0.3 pct, Euro STOXX 50 up 0.1 pct * Fugro tumbles 21 pct after saying it won't pay dividend * STMicro drops after warning on revenue By Blaise Robinson PARIS, Oct 29 - European stocks inched higher early on Wednesday, tracking sharp gains on Wall Street ahead of a U.S. Federal Reserve policy announcement. At 0900 GMT, the FTSEurofirst 300 index of top European shares was up 0.3 percent at 1,321.07 points, led by miners including Rio Tinto and

29 Oct 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks